These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 28624101)

  • 1. Reversal of liver fibrosis: From fiction to reality.
    Zoubek ME; Trautwein C; Strnad P
    Best Pract Res Clin Gastroenterol; 2017 Apr; 31(2):129-141. PubMed ID: 28624101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential.
    Kong D; Zhang F; Zhang Z; Lu Y; Zheng S
    Biomed Pharmacother; 2013 Apr; 67(3):246-50. PubMed ID: 23201010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of liver cirrhosis: current evidence and expectations.
    Jung YK; Yim HJ
    Korean J Intern Med; 2017 Mar; 32(2):213-228. PubMed ID: 28171717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to prevent and reverse liver fibrosis in humans and laboratory animals.
    Chen RJ; Wu HH; Wang YJ
    Arch Toxicol; 2015 Oct; 89(10):1727-50. PubMed ID: 25963329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver fibrosis: Direct antifibrotic agents and targeted therapies.
    Schuppan D; Ashfaq-Khan M; Yang AT; Kim YO
    Matrix Biol; 2018 Aug; 68-69():435-451. PubMed ID: 29656147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic fibrosis--role of hepatic stellate cell activation.
    Safadi R; Friedman SL
    MedGenMed; 2002 Jul; 4(3):27. PubMed ID: 12466770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of energy metabolism promotes antifibrotic effects in human hepatic stellate cells and prevents liver fibrosis in a mouse model.
    Karthikeyan S; Potter JJ; Geschwind JF; Sur S; Hamilton JP; Vogelstein B; Kinzler KW; Mezey E; Ganapathy-Kanniappan S
    Biochem Biophys Res Commun; 2016 Jan; 469(3):463-9. PubMed ID: 26525850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.
    Elpek GÖ
    World J Gastroenterol; 2014 Jun; 20(23):7260-76. PubMed ID: 24966597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro.
    Zhang Z; Guo Y; Zhang S; Zhang Y; Wang Y; Ni W; Kong D; Chen W; Zheng S
    Eur J Pharmacol; 2013 Dec; 721(1-3):133-40. PubMed ID: 24076327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathobiology of liver fibrosis: a translational success story.
    Lee YA; Wallace MC; Friedman SL
    Gut; 2015 May; 64(5):830-41. PubMed ID: 25681399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
    Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
    World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
    Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
    Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advancement of molecular mechanisms of liver fibrosis.
    Seki E; Brenner DA
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):512-8. PubMed ID: 25869468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
    Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of hepatic stellate cell activation as a therapeutic target for the treatment of non-alcoholic steatohepatitis].
    Tsuchida T
    Nihon Yakurigaku Zasshi; 2019; 154(4):203-209. PubMed ID: 31597900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of liver fibrosis: basic mechanisms and clinical relevance.
    Ramachandran P; Iredale JP; Fallowfield JA
    Semin Liver Dis; 2015 May; 35(2):119-31. PubMed ID: 25974898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy.
    Omar R; Yang J; Liu H; Davies NM; Gong Y
    Rev Physiol Biochem Pharmacol; 2016; 172():1-37. PubMed ID: 27534415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Succinate induces hepatic fibrogenesis by promoting activation, proliferation, and migration, and inhibiting apoptosis of hepatic stellate cells.
    Park SY; Le CT; Sung KY; Choi DH; Cho EH
    Biochem Biophys Res Commun; 2018 Feb; 496(2):673-678. PubMed ID: 29366478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis.
    Chen Z; Jain A; Liu H; Zhao Z; Cheng K
    J Pharmacol Exp Ther; 2019 Sep; 370(3):695-702. PubMed ID: 30886124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro.
    Yu J; Zhang S; Chu ES; Go MY; Lau RH; Zhao J; Wu CW; Tong L; Zhao J; Poon TC; Sung JJ
    Int J Biochem Cell Biol; 2010 Jun; 42(6):948-57. PubMed ID: 20156580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.